Sempra Q2 FY2025 Earnings Call
· Earnings call transcript and AI-powered summary
Quarterly Financial Performance
- Adjusted EPS: $0.89, flat versus Q2 2024 ($0.89).
- GAAP EPS: $0.71, down from $1.12 in Q2 2024, primarily due to lower income tax benefits and higher interest expense.
- First-Half Performance: Management reported steady execution and reaffirmed full-year 2025 adjusted EPS guidance of $4.30–$4.70 and 2026 EPS guidance of $4.80–$5.30.
Key Business Updates
Capital Investment and Value Creation Plan
- Sempra expects to deploy roughly $13 billion of capital in 2025, with $10 billion directed toward U.S. utilities.
- More than $5 billion deployed in the first half of 2025.
- Ongoing progress on cost-reduction initiatives through “Fit for 2025,” including technology upgrades, process improvements, and organizational restructuring.
Texas (Oncor)
- Oncor executing on its $36 billion 5-year capital plan (2025–2029).
- Evaluating $12 billion in incremental capital opportunities, not yet included in Sempra’s base capital plan.
- HB5247 passed in Texas, creating the Unified Tracker Mechanism (UTM), expected to increase earned ROE by 50–100 basis points over time.
- Oncor filed a comprehensive base rate review seeking updated O&M levels (based on a 2024 test year), higher equity layer (45% vs. 42.5%), and increased ROE (10.55% vs. 9.7%).
Continue Reading
Unlock the full AI-powered summary with key highlights, financial performance, and analyst Q&A.
Upgrade to ProfessionalContinue Reading
Unlock the full earnings call transcript with speaker labels and formatted dialogue.
Upgrade to Professional